Sarah  London net worth and biography

Sarah London Biography and Net Worth

CEO of Centene

Sarah London is CEO of Centene Corporation, a Fortune 50 company and leading national healthcare payer that takes a unique local approach to providing fully integrated, high-quality, and cost-effective services. Centene focuses on government-sponsored healthcare programs and primarily serves under-insured and uninsured individuals.

Ms. London has spent her career at the intersection of health data, technology and healthcare delivery transformation. Before her 2022 appointment to CEO, she was Centene’s Vice Chairman, responsible for strategy, technology, ancillary services, enterprise compliance and quality, as well as for Centene’s portfolio of independent, non health plan companies. Prior to Centene she was an Operating Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Previously, she held roles at Optum Analytics, first serving as Vice President of Client Services and then later becoming its Chief Product Officer, where she drove the strategy and commercialization of the company’s integrated data solutions for the provider, payer, and life sciences markets. She joined Optum after it acquired Humedica, a clinical analytics start-up, where she led the client services and operations team.

Ms. London’s career has been driven by her early experiences working to improve health care for people of all backgrounds, holding positions at Accretive Health (now R1 RCM), which works with health systems and providers on their revenue cycle to create greater financial stability and better patient experiences, and at Health Leads, a leading national organization that systemically addresses social determinants of health through data and unique community partnership models.

Ms. London graduated magna cum laude from Harvard College where she played Division I tennis. She also holds a Master of Business Administration with High Honors from the University of Chicago Booth School of Business.

What is Sarah London's net worth?

The estimated net worth of Sarah London is at least $40.53 million as of November 8th, 2024. Ms. London owns 667,229 shares of Centene stock worth more than $40,534,162 as of November 12th. This net worth evaluation does not reflect any other assets that Ms. London may own. Additionally, Ms. London receives an annual salary of $4,980,000.00 as CEO at Centene. Learn More about Sarah London's net worth.

How old is Sarah London?

Ms. London is currently 43 years old. There are 7 older executives and no younger executives at Centene. Learn More on Sarah London's age.

What is Sarah London's salary?

As the CEO of Centene Co., Ms. London earns $4,980,000.00 per year. Learn More on Sarah London's salary.

How do I contact Sarah London?

The corporate mailing address for Ms. London and other Centene executives is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. Centene can also be reached via phone at (314) 725-4477 and via email at [email protected]. Learn More on Sarah London's contact information.

Has Sarah London been buying or selling shares of Centene?

Over the course of the past ninety days, Sarah London has bought $250,313.60 of Centene stock. Most recently, on Friday, November 8th, Sarah London bought 4,117 shares of Centene stock. The stock was acquired at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the transaction, the chief executive officer now directly owns 667,229 shares of the company's stock, valued at $40,567,523.20. Learn More on Sarah London's trading history.

Who are Centene's active insiders?

Centene's insider roster includes Andrew Asher (Exec. VP & CFO ), Andrew Asher (CFO), Orlando Ayala (Director), Shannon Bagley (EVP), Mark Brooks (EVP), Kenneth Burdick (EVP), Brandy Burkhalter (COO), Katie Casso (SVP), Christopher Coughlin (Director), Robert Ditmore (Director), Kenneth Fasola (President), Richard Gephardt (Director), Jesse Hunter (NASDAQ), Christopher Koster (SVP), Brent Layton (EVP), Sarah London (CEO), Michael Neidorff (CEO), John Roberts (Director), Lori Robinson (Director), Theodore Samuels, II (Director), Jeffrey Schwaneke (CFO), David Thomas (EVP), Tommy Thompson (Director), and Colin Toney (EVP). Learn More on Centene's active insiders.

Are insiders buying or selling shares of Centene?

In the last twelve months, Centene insiders bought shares 1 times. They purchased a total of 4,117 shares worth more than $250,313.60. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 30,878 shares worth more than $2,363,286.50. The most recent insider tranaction occured on November, 8th when CEO Sarah London bought 4,117 shares worth more than $250,313.60. Insiders at Centene own 0.3% of the company. Learn More about insider trades at Centene.

Information on this page was last updated on 11/8/2024.

Sarah London Insider Trading History at Centene

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/8/2024Buy4,117$60.80$250,313.60667,229View SEC Filing Icon  
3/17/2023Buy30,000$62.60$1,878,000.00313,953View SEC Filing Icon  
See Full Table

Sarah London Buying and Selling Activity at Centene

This chart shows Sarah London's buying and selling at Centene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Centene Company Overview

Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $58.60
Low: $58.56
High: $61.25

50 Day Range

MA: $69.34
Low: $59.82
High: $80.21

2 Week Range

Now: $58.60
Low: $58.56
High: $81.42

Volume

6,070,742 shs

Average Volume

3,955,229 shs

Market Capitalization

$29.59 billion

P/E Ratio

10.17

Dividend Yield

N/A

Beta

0.49